PlainRecalls
ModerateActive

CPSC recall · Reported April 22, 2021

YYBA Recalls Welmate Lidocaine Numbing Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children …

Recall #
21737
Affected scope
About 15,000
Verify with CPSC →
View my saved recalls

Yash Pharmaceuticals, of India recalled This recall involves Welmate Lidocaine Numbing Cream in a 113 g (4 oz.) white jar with a … - a moderate-severity action.

YYBA Recalls Welmate Lidocaine Numbing Cream Due to Failure to Meet Child Resistant Packa… was recalled by Yash Pharmaceuticals, of India in April 22, 2021. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c…. Remedy: Consumers should immediately stop using the recalled cream, store it in a safe location o…. Verify recall #21737 with the CPSC before acting.

The recall

Yash Pharmaceuticals, of India issued this moderate-severity CPSC recall-The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c….

Moderate
severity level
April 22, 2021
reported

Sourced from official CPSC enforcement records. Verify recall #21737 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This CPSC action (record #21737) was formally reported on April 22, 2021. It is classified under Moderate severity, with a current status of Active. Yash Pharmaceuticals, of India is listed as the recalling firm. Federal records list the affected scope as About 15,000.

The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest i… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately stop using the recalled cream, store it in a safe location out of reach of children and contact YYBA for instructions on how to dispose of the product to receive a full r… - consumers holding this product should act on that instruction rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,731 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 146
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

About 15,000

Related Recalls

6

6 from same agency

Product description

This recall involves Welmate Lidocaine Numbing Cream in a 113 g (4 oz.) white jar with a blue, orange and green label and a white cap. "Welmate," "5% Lidocaine," the Welmate logo and UPC code 373581105045 or 373581000012 are printed on the label. The lot numbers and corresponding expiration dates included in the recall are printed on the underside of the jar as follows: Lot Numbers Expiration Dates ELNC2001 05/2022 ELNC2002 05/2022 EL5C2001 11/2022 EL5C2002 11/2022 EL5C2101 11/2022 EL5C2102 11/2022

Reason for recall

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.

Remedy, what to do

Consumers should immediately stop using the recalled cream, store it in a safe location out of reach of children and contact YYBA for instructions on how to dispose of the product to receive a full refund. YYBA is directly notifying all known consumers who purchased the recalled product on eBay, Walmart and wellspringmeds.com. Amazon is directly notifying all customers who purchased the recalled product on Amazon.com.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Moderate
Status Active
Recall number 21737
Date reported April 22, 2021
Date initiated April 22, 2021
Recalling firm Yash Pharmaceuticals, of India
Affected scope About 15,000
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately stop using the recalled cream, store it in a safe location out of reach of children and contact YYBA…

  • Check the recall number (21737) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
This recall involves Welmate Lidocaine Numbing Cream in a 113 g (4 oz.) white jar with a blue, orange and green label and a white cap. "Welmate," "5% Lidocaine," the Welmate logo and UPC code 373581105045 or 373581000012 are printed on the label. The lot numbers and corresponding expiration dates included in the recall are printed on the underside of the jar as follows: Lot Numbers Expiration Dates ELNC2001 05/2022 ELNC2002 05/2022 EL5C2001 11/2022 EL5C2002 11/2022 EL5C2101 11/2022 EL5C2102 11/2022. Recalled by Yash Pharmaceuticals, of India. Units affected: About 15,000.
Why was this product recalled?
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What should consumers do?
Consumers should immediately stop using the recalled cream, store it in a safe location out of reach of children and contact YYBA for instructions on how to dispose of the product to receive a full refund. YYBA is directly notifying all known consumers who purchased the recalled product on eBay, Walmart and wellspringmeds.com. Amazon is directly notifying all customers who purchased the recalled product on Amazon.com.
Which agency issued this recall?
This recall was issued by the CPSC on April 22, 2021. Severity: Moderate. Recall number: 21737.
How do I check if my product is affected by a recall?
Check the product description and recall number (21737) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported April 22, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.